| Repeatability and reproducibility of MRI-based radiomic features in cervical cancer S Fiset, ML Welch, J Weiss, M Pintilie, JL Conway, M Milosevic, A Fyles, ... Radiotherapy and Oncology 135, 107-114, 2019 | 149 | 2019 |
| Sensitivity of radiomic features to inter-observer variability and image pre-processing in Apparent Diffusion Coefficient (ADC) maps of cervix cancer patients A Traverso, M Kazmierski, ML Welch, J Weiss, S Fiset, WD Foltz, ... Radiotherapy and Oncology 143, 88-94, 2020 | 56 | 2020 |
| Prevalence and heterogeneity of PD-L1 expression by 22C3 assay in routine population-based and reflexive clinical testing in lung cancer DM Hwang, T Albaqer, RC Santiago, J Weiss, J Tanguay, M Cabanero, ... Journal of Thoracic Oncology, 2021 | 35 | 2021 |
| BRAF V600E mutation and MET amplification as resistance pathways of the second-generation anaplastic lymphoma kinase (ALK) inhibitor alectinib in lung cancer R Shi, SN Martins Filho, M Li, A Fares, J Weiss, NA Pham, O Ludkovski, ... Lung Cancer 146, 78-85, 2020 | 29 | 2020 |
| Clinical implementation of circulating tumour DNA testing for EGFR T790M for detection of treatment resistance in non-small cell lung cancer T Spence, S Perera, J Weiss, S Grenier, L Ranich, F Shepherd, ... Journal of Clinical Pathology 74 (2), 91-97, 2021 | 24 | 2021 |
| Integrative analysis of non-small cell lung cancer patient-derived xenografts identifies distinct proteotypes associated with patient outcomes S Mirhadi, S Tam, Q Li, N Moghal, NA Pham, J Tong, BJ Golbourn, ... Nature communications 13 (1), 1-17, 2022 | 22 | 2022 |
| Patient-derived tumor xenograft and organoid models established from resected pancreatic, duodenal and biliary cancers NA Pham, N Radulovich, E Ibrahimov, SN Martins-Filho, Q Li, M Pintilie, ... Scientific reports 11 (1), 1-12, 2021 | 18 | 2021 |
| Implementation of PD-L1 22C3 IHC pharmDxTM in Cell Block Preparations of Lung Cancer: Concordance with Surgical Resections and Technical Validation of CytoLyt® Prefixation SK Lou, HM Ko, T Kinoshita, S MacDonald, J Weiss, K Czarnecka-Kujawa, ... Acta cytologica 64 (6), 577-587, 2020 | 17 | 2020 |
| Targeting the ubiquitin-proteasome system using the UBA1 inhibitor TAK-243 is a potential therapeutic strategy for small cell lung cancer. S Majeed, MK Aparnathi, KCJ Nixon, V Venkatasubramanian, F Rahman, ... Clinical cancer research: an official journal of the American Association …, 2022 | 14 | 2022 |
| Meningioma screening with MRI in childhood leukemia survivors treated with cranial radiation JL Co, M Swain, LJ Murray, S Ahmed, NJ Laperriere, DS Tsang, E Yu, ... International Journal of Radiation Oncology* Biology* Physics 104 (3), 640-643, 2019 | 14 | 2019 |
| A Comparison of Hypofractionated and Twice-Daily Thoracic Irradiation in Limited-Stage Small-Cell Lung Cancer: An Overlap-Weighted Analysis M Yan, S Sigurdson, N Greifer, TAC Kennedy, TS Toh, PE Lindsay, ... Cancers 13 (12), 2895, 2021 | 12 | 2021 |
| Antitumor efficacy of XPO1 inhibitor Selinexor in KRAS-mutant lung adenocarcinoma patient-derived xenografts JC Rosen, J Weiss, NA Pham, Q Li, SN Martins-Filho, Y Wang, MS Tsao, ... Translational oncology 14 (10), 101179, 2021 | 10 | 2021 |
| Limited-stage small cell lung cancer: Outcomes associated with prophylactic cranial irradiation over a 20-year period at the Princess Margaret Cancer Centre M Yan, TS Toh, PE Lindsay, J Weiss, K Hueniken, C Yeung, V Sugumar, ... Clinical and Translational Radiation Oncology, 2021 | 8 | 2021 |
| Concurrent chemoradiation with or without durvalumab in elderly patients with unresectable stage 3 non-small cell lung cancer: safety and efficacy SCM Lau, M Ryan, J Weiss, AF Fares, M Garcia, S Schmid, S Kuang, ... JTO Clinical and Research Reports, 100251, 2021 | 7* | 2021 |
| Systemic Inflammatory Markers of Survival in Epidermal Growth Factor-mutated Non-Small Cell Lung Cancer: Single Institution Analysis, Systematic Review and Meta-Analysis SWS Chan, E Smith, R Aggarwal, K Balaratnam, RQ Chen, K Hueniken, ... Clinical Lung Cancer, 2021 | 7 | 2021 |
| Impact of EGFR mutation on outcomes following SRS for brain metastases in non-small cell lung cancer FY Moraes, A Mansouri, A Dasgupta, M Ramotar, N Kosyak, J Weiss, ... Lung Cancer 155, 34-39, 2021 | 6 | 2021 |
| Hypofractionation in Breast Cancer Radiotherapy Across World Bank Income Groups: Results of an International Survey M Mushonga, J Weiss, ZA Liu, AM Nyakabau, O Mohamad, B Tawk, ... JCO Global Oncology 9, e2200127, 2023 | 5 | 2023 |
| Mitochondrial aconitase ACO2 links iron homeostasis with tumorigenicity in non-small cell lung cancer. S Mirhadi, W Zhang, NA Pham, F Karimzadeh, M Pintilie, J Tong, P Taylor, ... Molecular Cancer Research: MCR, MCR-22, 2022 | 5 | 2022 |
| Multiplicity does not significantly affect outcomes in brain metastasis patients treated with surgery K Yang, E Gutierrez, AP Landry, A Kalyvas, M Millesi, M Leite, ... Neuro-Oncology Advances, 2022 | 5 | 2022 |
| Optimizing Drug Response Study Design in Patient-Derived Tumor Xenografts J Weiss, NA Pham, M Pintilie, M Li, G Liu, FA Shepherd, MS Tsao, W Xu Cancer informatics 21, 11769351221136056, 2022 | 4 | 2022 |
